Patents by Inventor Nicolas Tesson

Nicolas Tesson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SIPONIMOD SALTS AND COCRYSTALS
    Publication number: 20240010616
    Abstract: The presented invention relates to solid forms of Siponimod adipic acid salt and cocrystal.
    Type: Application
    Filed: September 24, 2021
    Publication date: January 11, 2024
    Inventors: Bohumil DYMACEK, Jiri PARTL, Nicolas TESSON, Montserrat TRILLA CASTANO
  • CO-CRYSTALS OF TRAMADOL AND COXIBS
    Publication number: 20230057884
    Abstract: The present invention relates to co-crystals of tramadol and co-crystal formers selected from NSAIDs/coxibs, processes for preparation of the same and their uses as medicaments or in pharmaceutical formulations, more particularly for the treatment of pain.
    Type: Application
    Filed: October 18, 2022
    Publication date: February 23, 2023
    Inventors: Carlos-Ramón PLATA-SALAMAN, Nicolas Tesson
  • Co-crystals of tramadol and coxibs
    Patent number: 11478488
    Abstract: The present invention relates to co-crystals of tramadol and co-crystal formers selected from NSAIDs/coxibs, processes for preparation of the same and their uses as medicaments or in pharmaceutical formulations, more particularly for the treatment of pain.
    Type: Grant
    Filed: December 19, 2019
    Date of Patent: October 25, 2022
    Assignee: ESTEVE PHARMACEUTICALS, S.A.
    Inventors: Carlos-Ramón Plata-Salaman, Nicolas Tesson
  • Apomorphine-palmitic acid cocrystal solid particle crystalline form
    Patent number: 11382867
    Abstract: A pharmaceutical composition comprising apomorphine (APO) in a solid crystalline form, wherein the solid crystalline form is an APO·palmitic acid cocrystal solid particle crystalline form.
    Type: Grant
    Filed: January 15, 2019
    Date of Patent: July 12, 2022
    Assignee: LEUKOS BIOTECH, S. L.
    Inventors: Enrique Llaudet Carles, Nicolas Tesson, Montserrat Trilla Castaño
  • Highly stable crystalline Eltrombopag monoethanolamine salt form D1
    Patent number: 11267791
    Abstract: Object of the present invention is a highly stable crystalline form of Eltrombopag (ETP) monoethanolamine salt, named Form D1, having the highest thermodynamically stability with excellent non-hygroscopicity, and particularly well suitable for pharmaceutical purposes, with related process.
    Type: Grant
    Filed: July 25, 2019
    Date of Patent: March 8, 2022
    Assignee: F.I.S.—FABBRICA ITALIANA SINTETICI S.P.A.
    Inventors: Nicolas Tesson, Jordi De Mier Vinue, Paolo Stabile, Pierluigi Padovan, Matteo De Poli, Angelo Restelli
  • Salts of (R)-9-(2,5-difluorophenethyl)-4-ethyl-2-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one
    Patent number: 11236110
    Abstract: The present invention relates to (R)-9-(2,5-difluorophenethyl)-4-ethyl-2-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one salts, to pharmaceutical compositions comprising them, and to their use in therapy and/or prophylaxis of sigma receptor and/or ?-opioid receptor associated disease.
    Type: Grant
    Filed: October 16, 2018
    Date of Patent: February 1, 2022
    Assignee: ESTEVE PHARMACEUTICALS, S.A.
    Inventors: Carmen Almansa-Rosales, Nicolas Tesson
  • Crystalline Eltrombopag monoethanolamine salt form D
    Patent number: 11214547
    Abstract: Object of the present invention is a better crystalline form of Eltrombopag (ETP) monoethanolamine salt, named Form D, stable, suitable for pharmaceutical purposes, and with the highest solubility in water and excellent non-hygroscopicity, then the related process and intermediates thereof.
    Type: Grant
    Filed: July 25, 2019
    Date of Patent: January 4, 2022
    Assignee: F.I.S.—FABBRICA ITALIANA SINTETICI S.P.A.
    Inventors: Nicolas Tesson, Jordi De Mier Vinue, Paolo Stabile, Pierluigi Padovan, Matteo De Poli, Angelo Restelli
  • SOLID COMPOSITIONS OF COCRYSTALS OF CANNABINOIDS
    Publication number: 20210380514
    Abstract: The present invention relates to solid compositions comprising cocrystals of cannabinoids, processes for their preparation, and their use as in therapy or in cosmetics or for the purification of cannabinoids. It also relates to cocrystals of cannabinoids.
    Type: Application
    Filed: October 31, 2019
    Publication date: December 9, 2021
    Inventors: Nicolas TESSON, Montserrat TRILLA CASTAÑO, Alexander Christian COMELY
  • Cocrystal of 2-[(1R,6R)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-5-pentylbenzene-l,3-diol
    Patent number: 11168047
    Abstract: The present invention relates to cocrystals of 2-[(1R,6R)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol and a zwitterion coformer, processes for their preparation, and their use as a medicament and for the purification of 2-[(1R,6R)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol. The invention also relates to compositions comprising the cocrystal.
    Type: Grant
    Filed: August 6, 2018
    Date of Patent: November 9, 2021
    Assignee: ENANTIA, S.L.
    Inventors: Alexander Christian Comely, Nicolas Tesson, Carmen Jiménez González
  • HIGHLY STABLE CRYSTALLINE ELTROMBOPAG MONOETHANOLAMINE SALT FORM D1
    Publication number: 20210284611
    Abstract: Object of the present invention is a highly stable crystalline form of Eltrombopag (ETP) monoethanolamine salt, named Form D1, having the highest thermodynamically stability with excellent non-hygroscopicity, and particularly well suitable for pharmaceutical purposes, with related process.
    Type: Application
    Filed: July 25, 2019
    Publication date: September 16, 2021
    Applicant: F.I.S. - FABBRICA ITALIANA SINTETICI S.P.A.
    Inventors: Nicolas TESSON, Jordi DE MIER VINUE, Paolo STABILE, Pierluigi PADOVAN, Matteo DE POLI, Angelo RESTELLI
  • CRYSTALLINE ELTROMBOPAG MONOETHANOLAMINE SALT FORM D
    Publication number: 20210198211
    Abstract: Object of the present invention is a better crystalline form of Eltrombopag (ETP) monoethanolamine salt, named Form D, stable, suitable for pharmaceutical purposes, and with the highest solubility in water and excellent non-hygroscopicity, then the related process and intermediates thereof.
    Type: Application
    Filed: July 25, 2019
    Publication date: July 1, 2021
    Applicant: F.I.S. - FABBRICA ITALIANA SINTETICI S.P.A.
    Inventors: Nicolas TESSON, Jordi DE MIER VINUE, Paolo STABILE, Pierluigi PADOVAN, Matteo DE POLI, Angelo RESTELLI
  • APOMORPHINE-PALMITIC ACID COCRYSTAL SOLID PARTICLE CRYSTALLINE FORM
    Publication number: 20200405648
    Abstract: A pharmaceutical composition comprising apomorphine (APO) in a solid crystalline form, wherein the solid crystalline form is an APO·palmitic acid cocrystal solid particle crystalline form.
    Type: Application
    Filed: January 15, 2019
    Publication date: December 31, 2020
    Inventors: Enrique LLAUDET CARLES, Nicolas TESSON, Montserrat TRILLA CASTAÑO
  • A COCRYSTAL OF 2-[(1R,6R)-6-ISOPROPENYL-3-METHYLCYCLOHEX-2-EN-1-YL]-5-PENTYLBENZENE-1,3-DIOL
    Publication number: 20200369586
    Abstract: The present invention relates to cocrystals of 2-[(1R,6R)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol and a zwitterion coformer, processes for their preparation, and their use as a medicament and for the purification of 2-[(1R,6R)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol. The invention also relates to compositions comprising the cocrystal.
    Type: Application
    Filed: August 6, 2018
    Publication date: November 26, 2020
    Inventors: Alexander Christian COMELY, Nicolas TESSON, Carmen JIMÉNEZ GONZÁLEZ
  • SALTS OF (R)-9-(2,5-DIFLUOROPHENETHYL)-4-ETHYL-2-METHYL-1-OXA-4,9-DIAZASPIRO[5.5]UNDECAN-3-ONE
    Publication number: 20200331929
    Abstract: The present invention relates to (R)-9-(2,5-difluorophenethyl)-4-ethyl-2-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one salts, to pharmaceutical compositions comprising them, and to their use in therapy and/or prophylaxis of sigma receptor and/or ?-opioid receptor associated disease.
    Type: Application
    Filed: October 16, 2018
    Publication date: October 22, 2020
    Inventors: Carmen ALMANSA-ROSALES, Nicolas TESSON
  • Process for preparing fluorescein quinoid form
    Patent number: 10745373
    Abstract: The present invention relates to a process for preparing fluorescein quinoid form of Formula (I): Furthermore, the present invention relates to a new solid fluorescein form and a process for the preparation thereof. The present invention also relates to the use of said new solid fluorescein form in the synthesis of fluorescein quinoid form.
    Type: Grant
    Filed: July 31, 2019
    Date of Patent: August 18, 2020
    Assignee: Delmar Chemicals Inc.
    Inventors: Nicolas Tesson, Eduard Bugan, Nadejda Spassova, Alain Menard
  • CO-CRYSTALS OF TRAMADOL AND COXIBS
    Publication number: 20200171055
    Abstract: The present invention relates to co-crystals of tramadol and co-crystal formers selected from NSAIDs/coxibs, processes for preparation of the same and their uses as medicaments or in pharmaceutical formulations, more particularly for the treatment of pain.
    Type: Application
    Filed: December 19, 2019
    Publication date: June 4, 2020
    Inventors: Carlos-Ramón PLATA-SALAMAN, Nicolas TESSON
  • Co-crystals of tramadol and coxibs
    Patent number: 10548909
    Abstract: The present invention relates to co-crystals of tramadol and co-crystal formers selected from NSAIDs/coxibs, processes for preparation of the same and their uses as medicaments or in pharmaceutical formulations, more particularly for the treatment of pain.
    Type: Grant
    Filed: February 14, 2019
    Date of Patent: February 4, 2020
    Assignee: ESTEVE PHARMACEUTICALS, S.A.
    Inventors: Carlos Ramon Plata Salaman, Nicolas Tesson
  • CHIRAL RESOLUTION OF AN INTERMEDIATE OF SUVOREXANT AND COCRYSTALS THEREOF
    Publication number: 20190276414
    Abstract: Relating to processes for preparing suvorexant or its pharmaceutically acceptable salts through the formation of a cocrystal of (R)-benzyl 5-methyl-1,4-diazepane-1-carboxylate hydrochloride with (R)-(+)-1,1,2-triphenyl-1,2-ethanediol ((R)-TED). This cocrystal provides the resolution of an intermediate of suvorexant, in particular, of (rac)-benzyl5-methyl-1,4-diazepane-1-carboxy-lateor a hydrochloride salt thereof. It also relates to a new cocrystal useful in such preparation processes.
    Type: Application
    Filed: June 2, 2017
    Publication date: September 12, 2019
    Inventors: Alexander Christian COMELY, Nicolas TESSON
  • CO-CRYSTALS OF TRAMADOL AND COXIBS
    Publication number: 20190231800
    Abstract: The present invention relates to co-crystals of tramadol and co-crystal formers selected from NSAIDs/coxibs, processes for preparation of the same and their uses as medicaments or in pharmaceutical formulations, more particularly for the treatment of pain.
    Type: Application
    Filed: February 14, 2019
    Publication date: August 1, 2019
    Applicant: LABORATORIOS DEL DR. ESTEVE, S.A.
    Inventors: Carlos Ramon PLATA SALAMAN, Nicolas TESSON
  • Co-crystals of tramadol and coxibs
    Patent number: 10245276
    Abstract: The present invention relates to co-crystals of tramadol and co-crystal formers selected from NSAIDs/coxibs, processes for preparation of the same and their uses as medicaments or in pharmaceutical formulations, more particularly for the treatment of pain.
    Type: Grant
    Filed: August 9, 2016
    Date of Patent: April 2, 2019
    Assignee: LABORATORIOS DEL DR. ESTEVE, S.A.
    Inventors: Carlos Ramon Plata Salaman, Nicolas Tesson